A61K33/20

Antimicrobial compositions and methods
09744191 · 2017-08-29 · ·

Disclosed are compositions and methods for antimicrobial use. The compositions contain a small antimicrobial agent and a permeabilizing agent. The antimicrobial compositions can be antifungal or antibacterial compositions.

Antimicrobial compositions and methods
09744191 · 2017-08-29 · ·

Disclosed are compositions and methods for antimicrobial use. The compositions contain a small antimicrobial agent and a permeabilizing agent. The antimicrobial compositions can be antifungal or antibacterial compositions.

Isotonic crystalloid aqueous solution
11426427 · 2022-08-30 · ·

The invention relates to an isotonic crystalloid aqueous solution of the type containing Na.sup.+, K.sup.+ and Cl.sup.−, and to the use thereof as a vasodilator.

Isotonic crystalloid aqueous solution
11426427 · 2022-08-30 · ·

The invention relates to an isotonic crystalloid aqueous solution of the type containing Na.sup.+, K.sup.+ and Cl.sup.−, and to the use thereof as a vasodilator.

COMPOSITION AND METHOD FOR THE TREATMENT OF MUCOUS MEMBRANE INFLAMMATION
20170232039 · 2017-08-17 ·

A method for treating mucous membrane inflammation in a patient is provided. The method includes administering an effective amount of a composition containing sodium salts to the patient. Preferably, the composition contains a sodium concentration of less than or equal to 125 mM, and contains sodium hypochlorite and a sodium salt of N-chlorotaurine.

COMPOSITION AND METHOD FOR THE TREATMENT OF MUCOUS MEMBRANE INFLAMMATION
20170232039 · 2017-08-17 ·

A method for treating mucous membrane inflammation in a patient is provided. The method includes administering an effective amount of a composition containing sodium salts to the patient. Preferably, the composition contains a sodium concentration of less than or equal to 125 mM, and contains sodium hypochlorite and a sodium salt of N-chlorotaurine.

COMPOSITION AND METHOD FOR THE TREATMENT OF MUCOUS MEMBRANE INFLAMMATION
20170232039 · 2017-08-17 ·

A method for treating mucous membrane inflammation in a patient is provided. The method includes administering an effective amount of a composition containing sodium salts to the patient. Preferably, the composition contains a sodium concentration of less than or equal to 125 mM, and contains sodium hypochlorite and a sodium salt of N-chlorotaurine.

CELL REPAIR AGENT AND DISINFECTION SYSTEM
20170231949 · 2017-08-17 · ·

A cell repair agent capable of repairing cells damaged by the oxidizing power of acidic electrolyzed water or the like, and, a disinfection system capable of safely and efficiently accelerating the sterilization and cure of infected skin or intraoral wounds. The cell repair agent includes at least one type of a polyphenol represented by the following general formula (1), a polymer thereof, and a pharmaceutically acceptable salt thereof. R.sub.2 and R.sub.3 are preferably hydrogen atoms, and R.sub.1 is preferably a hydrogen atom or a hydroxyl group.

##STR00001##

CELL REPAIR AGENT AND DISINFECTION SYSTEM
20170231949 · 2017-08-17 · ·

A cell repair agent capable of repairing cells damaged by the oxidizing power of acidic electrolyzed water or the like, and, a disinfection system capable of safely and efficiently accelerating the sterilization and cure of infected skin or intraoral wounds. The cell repair agent includes at least one type of a polyphenol represented by the following general formula (1), a polymer thereof, and a pharmaceutically acceptable salt thereof. R.sub.2 and R.sub.3 are preferably hydrogen atoms, and R.sub.1 is preferably a hydrogen atom or a hydroxyl group.

##STR00001##

Sodium hypochlorite-based body wash compositions
09730870 · 2017-08-15 · ·

Sodium hypochlorite-based compositions that are non-toxic and have antimicrobial and cleansing properties may include from about 0.025% to about 10% by weight of sodium hypochlorite. For example, the compositions may include less than 1% by weight of sodium hypochlorite (e.g., less than 0.5% by weight of sodium hypochlorite). The compositions may further include sodium laureth sulfate, cocamidopropyl betaine, cocamide MEA, disodium EDTA, and deionized water. Such compositions may be applied externally to a mammalian body through rinse-off or leave-on applications. Compositions also may be incorporated as a component of other products, such as deodorants, towelettes, or powders.